• Home
  • A-B index
  • Pharmacological Index
  • Drug Classes
  • Active Ingredients
  • Companies
  • News
  • Teriflunomide Teva
    / Teva


    Active Ingredient

    Status in Israel
    RX

    Presentation and Status in Health Basket

    Presentation Basket Yarpa Pharmasoft

    Film Coated Tablets

    28 X 14 mg

    not in the basket chart 30663

    Related information


    Dosage

    The recommended dosage is one Dosage coated tablet (14 mg) per day.


    Indications

    Treatment of adult patients with relapsing remitting forms of Multiple Sclerosis (MS) to reduce the frequency of clinical relapses and to delay the progression of physical disability.


    Contra-Indications

    Hypersensitivity to active substance.
    Pregnancy, lactation.
    Severe  hepatic impairment.
    Immunologic disorders (e.g. AIDS).
    Bone marrow disorders (e.g.: anemia, leucopenia, thrombocytopenia).
    Patients with severe infections.
    Patients with renal impairment that require dialysis.
    Patients with hypoproteinemia.


    Special Precautions

    Please refer to the license holder for further details.


    Side Effects

    Please refer to the license holder for further details.


    Drug interactions

    Please refer to the license holder for further details.


    Pregnancy and Lactation

    Please refer to the license holder for further details.


    Overdose

    Please refer to the license holder for further details.


    Manufacturer
    Teva Pharmaceutical Industries Ltd, Israel
    CLOSE